Possible protective effect of serum β-carotene levels on the association between interleukin-1B C-31T polymorphism and hypertension in a Japanese population

Clinical Nutrition

Volumn 28, Issue 2, 2009, Pages 198-202

  Yanagisawa, Atsumi ^a   Suzuki, Koji ^a   Kimura, Asami ^a   Ito, Yoshinori ^b   Hamajima, Nobuyuki ^b   Inoue, Takashi ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

carotene; Hypertension; Interleukin 1 ; Polymorphism

Indexed keywords

BETA CAROTENE; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; VITAMIN BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; BETA CAROTENE; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; INTERLEUKIN-1BETA; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SEX DISTRIBUTION; VITAMINS;

EID: 63549084141     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.01.020     Document Type: Article

References (29)

1. Biasucci L.M., Liuzzo G., Fantuzzi G., Caligiuri G., Rebuzzi A.G., Ginnetti F., et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99 (1999) 2079-2084
2. Fichtlscherer S., Rosenberger G., Walter D.H., Breuer S., Dimmeler S., and Zeiher A.M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102 (2000) 1000-1006
3. Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., and Ridker P.M. C-Reactive protein and the risk of developing hypertension. JAMA 290 (2003) 2945-2951
4. Li J., Doerffel Y., Hocher B., and Unger T. Inflammation in the genesis of hypertension and its complications the role of angiotensin II. Nephrol Dial Transplant 22 (2007) 3107-3109
5. Dalekos G.N., Elisaf M., Bairaktari E., Tsolas O., and Siamopoulos K.C. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?. J Lab Clin Med 129 (1997) 283-284
6. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
7. Huang G., Niu T., Peng S., Ling D., Liu J., Zhang X., et al. Association between the interleukin-1B C-511T polymorphism and blood pressure in a Chinese hypertensive population. Immunol Lett 91 (2004) 159-162
8. Lin R.C., and Morris B.J. Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension. Am J Med Genet 107 (2002) 311-316
9. Hamajima N., Matsuo K., Saito T., Tajima K., Okuma K., Yamao K., et al. Interleukin 1 polymorphism, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 92 (2001) 383-389
10. Kimura R., Nishioka T., Soemantri A., and Ishida T. Cis-acting effect of the IL1B C-31T polymorphism on IL-1beta mRNA expression. Genes Immun 5 (2004) 572-575
11. Bai S.K., Lee S.J., Na H.J., Ha K.S., Han J.A., Lee H., et al. β-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation. Exp Mol Med 37 (2005) 323-334
12. van Kappel A.L., Steghens J.P., Zeleniuch-Jacquotte A., Chajès V., Toniolo P., and Riboli E. Serum carotenoids as biomarkers of fruit and vegetable consumption in the New York Women's Health study. Public Health Nutr 4 (2000) 829-835
13. Kritchevsky S.B., Bush A.J., Pahor M., and Gross M.D. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol 152 (2000) 1065-1071
14. Chen J., He J., Hamm L., Batuman V., and Whelton P.K. Serum antioxidant vitamins and blood pressure in the United States population. Hypertension 40 (2002) 810-816
15. lto Y., Suzuki S., Yagyu K., Sasaki R., Suzuki K., and Aoki K. Relationship between serum carotenoid levels and cancer death rates in the residents, living in a rural area of Hokkaido. Japan J Epidemiology 7 (1997) 1-8
16. Matsuzawa Y., Inoue S., Ikeda Y., Sakata T., Saito Y., Sato Y., et al. The new diagnostic criteria of obesity. [in Japanese]. J Jpn Soc Study Obes 6 (2000) 18-28
17. Ito Y., Sasaki R., Minohara M., Otani M., and Aoki K. Quantitation of serum carotenoid concentrations in healthy inhabitants by high-performance liquid chromatography. Clin Chim Acta 169 (1987) 197-208
18. Ito Y., Ochiai J., Sasaki R., Suzuki S., Kusuhara Y., Morimitsu Y., et al. Serum concentrations of carotenoids, retinol, and a -tocopherol in healthy persons determined by high-performance liquid chromatography. Clin Chim Acta 194 (1990) 131-144
19. Atsuta Y., Kawase H., and Hamajima N. Use of duplex PCR-CTPP methods for CYP2E1RsaI/IL-2 T-330G and IL-1B C-31T/TNF-A T-1031C polymorphisms. Mol Diagn 9 (2005) 89-94
20. Peeters A.C., Netea M.G., Janssen M.C., Kullberg B.J., Van der Meer J.W., and Thien T. Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest 31 (2001) 31-36
21. Lip G.Y., Blann A.D., and Beevers D.G. Helicobacter pylori seropositivity, lipid concentrations and haemostatic factors. J Intern Med 248 (2000) 354-356
22. Hall S.K., Perregaux D.G., Gabel C.A., Woodworth T., Durham L.K., Huizinga T.W., et al. Correction of polymorphic variation in the promoter region of the interleukin-1β gene with secretion of interleukin-1β protein. Arthritis Rheum 50 (2004) 1976-1983
23. Pociot F., Mølvig J., Wogensen L., Worsaae H., and Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22 (1992) 396-402
24. Hulkkonen J., Vilpo J., Vilpo L., Koski T., and Hurme M. Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica 85 (2000) 600-606
25. Takamatsu M., Yamauchi M., Maezawa Y., Saito S., Maeyama S., and Uchikoshi T. Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 95 (2000) 1305-1311
26. Bloxham C.A., Beevers D.G., and Walker J.M. Malignant hypertension and cigarette smoking. Br Med J 1 (1979) 581-583
27. Marmot M.G., Elliott P., Shipley M.J., Dyer A.R., Ueshima H., Beevers D.G., et al. Alcohol and blood pressure: the INTERSALT study. Br Med J 308 (1994) 1263-1267
28. Stryker W.S., Kaplan L.A., Stein E.A., Stampfer M.J., Sober A., and Willett W.C. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 127 (1988) 283-296
29. Coylewright M., Reckelhoff J.F., and Ouyang P. Menopause and hypertension: an age-old debate. Hypertension 51 (2008) 952-959